Variant report

Variant	nsv892654
Chromosome Location	chr9:16898603-16941006
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 2215 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:2215 , 50 per page) page: 1 2 3 4 5 6 7 ... 45

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs954858	chr9:16898603-16898604	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs368180151	chr9:16898623-16898624	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs144845256	chr9:16898638-16898639	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs148278207	chr9:16898657-16898658	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs80127884	chr9:16898717-16898718	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs571825002	chr9:16898721-16898722	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs77190868	chr9:16898732-16898733	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs193168834	chr9:16898738-16898739	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs533318743	chr9:16898739-16898740	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs954857	chr9:16898753-16898754	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs35194519	chr9:16898794-16898795	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs566577248	chr9:16898811-16898812	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs150769752	chr9:16898818-16898819	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs566227550	chr9:16898853-16898854	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs10738464	chr9:16898855-16898856	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs138060163	chr9:16898873-16898874	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs10738465	chr9:16898879-16898880	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs543452405	chr9:16898903-16898904	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs557263542	chr9:16898907-16898908	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs569190455	chr9:16898910-16898911	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs578054365	chr9:16898946-16898947	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs370464047	chr9:16898966-16898967	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs551817766	chr9:16899025-16899026	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs558031369	chr9:16899044-16899045	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs372800629	chr9:16899049-16899050	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs373203698	chr9:16899053-16899054	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs572886098	chr9:16899057-16899058	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs34358697	chr9:16899083-16899084	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs555322060	chr9:16899089-16899090	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs7019028	chr9:16899090-16899091	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs74843954	chr9:16899099-16899100	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs76343549	chr9:16899100-16899101	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs185398662	chr9:16899113-16899114	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs189047494	chr9:16899118-16899119	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs10810660	chr9:16899120-16899121	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs577364005	chr9:16899149-16899150	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs545191321	chr9:16899179-16899180	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs560353142	chr9:16899185-16899186	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs527767538	chr9:16899228-16899229	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs10756833	chr9:16899267-16899268	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs149479033	chr9:16899270-16899271	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs62543561	chr9:16899285-16899286	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs550207941	chr9:16899305-16899306	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs569125438	chr9:16899306-16899307	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs539784642	chr9:16899385-16899386	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs112714068	chr9:16899428-16899429	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs192669221	chr9:16899431-16899432	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs10119493	chr9:16899464-16899465	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs10119513	chr9:16899526-16899527	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs147175545	chr9:16899528-16899529	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Glioblastoma multiforme	18628472	CNVD
Breast cancer	21611746	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:95 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:16898400-16900400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr9:16899200-16900200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
3	chr9:16899200-16900200	Enhancers	HUES64 Cell Line	embryonic stem cell
4	chr9:16899400-16900000	Enhancers	ES-I3 Cell Line	embryonic stem cell
5	chr9:16899400-16900200	Enhancers	HUES48 Cell Line	embryonic stem cell
6	chr9:16899400-16900200	Enhancers	HUES6 Cell Line	embryonic stem cell
7	chr9:16899400-16900200	Enhancers	iPS-15b Cell Line	embryonic stem cell
8	chr9:16899400-16900200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
9	chr9:16899600-16900000	Enhancers	H9 Cell Line	embryonic stem cell
10	chr9:16899600-16900000	Enhancers	iPS-18 Cell Line	embryonic stem cell
11	chr9:16899600-16900000	Enhancers	iPS-20b Cell Line	embryonic stem cell
12	chr9:16899600-16900200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
13	chr9:16899800-16900200	Enhancers	NHDF-Ad	bronchial
14	chr9:16900000-16900400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
15	chr9:16900200-16901400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr9:16901400-16902000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr9:16901600-16902000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr9:16902000-16914800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr9:16908200-16908600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
20	chr9:16911800-16912800	Enhancers	Muscle Satellite Cultured Cells	--
21	chr9:16911800-16912800	Enhancers	A549	lung
22	chr9:16912200-16912800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
23	chr9:16912200-16912800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
24	chr9:16912200-16912800	Enhancers	Osteobl	bone
25	chr9:16912800-16914800	Weak transcription	Osteobl	bone
26	chr9:16912800-16915200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
27	chr9:16912800-16921800	Weak transcription	Muscle Satellite Cultured Cells	--
28	chr9:16912800-16928000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr9:16914800-16915000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr9:16914800-16915600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr9:16914800-16915600	Enhancers	Adipose Nuclei	Adipose
32	chr9:16914800-16915800	Enhancers	Osteobl	bone
33	chr9:16915000-16915200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr9:16915000-16915600	Enhancers	NHDF-Ad	bronchial
35	chr9:16915200-16915400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr9:16915200-16915600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
37	chr9:16915200-16915800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
38	chr9:16915400-16915800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
39	chr9:16915400-16915800	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr9:16915400-16915800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr9:16915400-16915800	ZNF genes & repeats	Foreskin Melanocyte Primary Cells skin01	Skin
42	chr9:16915400-16915800	Enhancers	Psoas Muscle	Psoas
43	chr9:16915400-16915800	Enhancers	HSMM	muscle
44	chr9:16915800-16918800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
45	chr9:16915800-16921600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
46	chr9:16915800-16923600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr9:16915800-16928200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
48	chr9:16916400-16916600	Enhancers	Right Atrium	heart
49	chr9:16918600-16919600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
50	chr9:16918800-16919000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links